Published in J Cancer Surviv on November 10, 2016
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol (1993) 18.75
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist (2013) 4.33
The Work Limitations Questionnaire. Med Care (2001) 3.31
Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials (2004) 2.66
Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. Eur J Cancer (2008) 1.77
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol (2015) 1.44
Identifying Social Distress: A Cross-Sectional Survey of Social Outcomes 12 to 36 Months After Colorectal Cancer Diagnosis. J Clin Oncol (2015) 1.44
Work ability and return-to-work in cancer patients. Br J Cancer (2008) 1.35
Exploring the economic impact of breast cancers during the 18 months following diagnosis. Psychooncology (2007) 1.33
Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology (2012) 1.24
The development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer (2014) 1.21
The CARES: a generic measure of health-related quality of life for patients with cancer. Qual Life Res (1992) 1.20
The cost of cancer home care to families. Cancer (1993) 1.18
Patient-oncologist cost communication, financial distress, and medication adherence. J Oncol Pract (2014) 1.17
Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res (2010) 1.17
Development and validation of a psychosocial screening instrument for cancer. Health Qual Life Outcomes (2005) 1.17
Cancer survivors' views of work 3 years post diagnosis: a UK perspective. Eur J Oncol Nurs (2008) 1.16
Social problems in oncology. Br J Cancer (2002) 1.15
Using the illness intrusiveness ratings scale to understand health-related quality of life in chronic disease. J Psychosom Res (2009) 1.14
Does economic burden influence quality of life in breast cancer survivors? Gynecol Oncol (2011) 1.13
The meaning of work and working life after cancer: an interview study. Psychooncology (2008) 1.09
Advances in Patient-Reported Outcomes: The NIH PROMIS(®) Measures. EGEMS (Wash DC) (2013) 1.07
Development and evaluation of an instrument to assess social difficulties in routine oncology practice. Qual Life Res (2005) 1.06
I could lose everything: understanding the cost of a brain tumor. J Neurooncol (2007) 1.04
Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist (2001) 1.04
Family and out-of-pocket costs for women with breast cancer. Cancer Pract (1994) 1.04
Hot flashes, fatigue, treatment exposures and work productivity in breast cancer survivors. J Cancer Surviv (2008) 1.02
Work productivity in brain tumor survivors. J Occup Environ Med (2007) 1.00
Changes in employment and household income during the 24 months following a cancer diagnosis. Support Care Cancer (2008) 0.99
The quality of life of long-term survivors of Hodgkin's disease. Ann Oncol (1994) 0.97
"It's at a time in your life when you are most vulnerable": a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health. PLoS One (2013) 0.97
The personal financial burden of complications after colorectal cancer surgery. Cancer (2014) 0.97
Assessment of the impact of cancer on work, recreation, home management and sleep using a general health status measure. J R Soc Med (1994) 0.94
Return-to-work experiences of people with cancer. Oncol Nurs Forum (1993) 0.93
Psychosocial difficulties, deprivation and cancer: three questionnaire studies involving 609 cancer patients. Br J Cancer (2005) 0.93
The meaning of cancer: implications for family finances and consequent impact on lifestyle, activities, roles and relationships. Psychooncology (2011) 0.92
Psychosocial effects of cancer economics on patients and their families. Cancer (1993) 0.92
Screening for social difficulties in cancer patients: clinical utility of the Social Difficulties Inventory. Br J Cancer (2007) 0.91
Measuring psychosocial distress and parenting concerns among adults with cancer: the Parenting Concerns Questionnaire. Cancer (2012) 0.90
Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg (2011) 0.90
Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional study. BMJ Open (2011) 0.89
The psychosocial impact of cervical cancer among affected women and their partners. Int J Gynecol Cancer (2005) 0.89
Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psychooncology (2006) 0.89
The perceived cancer-related financial hardship among patients and their families: a systematic review. Support Care Cancer (2014) 0.89
Financial Distress and Its Associations With Physical and Emotional Symptoms and Quality of Life Among Advanced Cancer Patients. Oncologist (2015) 0.88
The Social Difficulties Inventory (SDI): development of subscales and scoring guidance for staff. Psychooncology (2011) 0.87
Measuring social difficulties in routine patient-centred assessment: a Rasch analysis of the social difficulties inventory. Qual Life Res (2007) 0.87
How do tangible supports impact the breast cancer experience? Soc Work Health Care (2005) 0.86
Financial Hardship--an Unwanted Consequence of Cancer Treatment. Curr Hematol Malig Rep (2015) 0.86
Socioeconomic disparities in psychosocial wellbeing in cancer patients. Eur J Cancer (2008) 0.86
The impact of colorectal cancer and self-efficacy beliefs on work ability and employment status: a longitudinal study. Eur J Cancer Care (Engl) (2012) 0.85
Is cancer survivorship associated with reduced work engagement? A NOCWO Study. J Cancer Surviv (2008) 0.85
Parenting concerns, quality of life, and psychological distress in patients with advanced cancer. Psychooncology (2015) 0.84
Access to care and impacts of cancer on daily life: do they differ for metropolitan versus regional hematological cancer survivors? J Rural Health (2013) 0.84
The Working After Cancer Study (WACS): a population-based study of middle-aged workers diagnosed with colorectal cancer and their return to work experiences. BMC Public Health (2011) 0.84
Economic hardship of minority and non-minority cancer survivors 1 year after diagnosis: another long-term effect of cancer? Cancer (2015) 0.83
Measurement and interpretation of social distress using the social difficulties inventory (SDI). Eur J Cancer (2008) 0.82
'It is hard for mums to put themselves first': how mothers diagnosed with breast cancer manage the sociological boundaries between paid work, family and caring for the self. Soc Sci Med (2014) 0.82
Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls. Breast Cancer Res Treat (2009) 0.81
Parenting changes in adults with cancer. Cancer (2015) 0.81
Patient Attitudes Regarding the Cost of Illness in Cancer Care. Oncologist (2015) 0.80
Patients' experiences following breast cancer treatment: an exploratory survey of personal and work experiences of breast cancer patients from three European countries. Eur J Cancer Care (Engl) (2014) 0.80
Trajectories of illness intrusiveness domains following a diagnosis of breast cancer. Health Psychol (2013) 0.80
Do ongoing lifestyle disruptions differ across cancer types after the conclusion of cancer treatment? J Cancer Surviv (2010) 0.79
Family routines and rituals when a parent has cancer. Fam Syst Health (2009) 0.78
Patient-reported outcome measures for cancer caregivers: a systematic review. Qual Life Res (2016) 0.78
The Rapid Emergence of Novel Therapeutics in Advanced Malignant Melanoma. Dermatol Ther (Heidelb) (2015) 0.78
Illness intrusiveness among survivors of autologous blood and marrow transplantation. Cancer (2001) 0.78
An exploratory qualitative analysis of the emotional impact of breast cancer and caregiving among older women. Care Manag J (2003) 0.78
Using patient-reported outcomes in clinical oncology practice: benefits, challenges and next steps. Expert Rev Pharmacoecon Outcomes Res (2006) 0.77
Non-medical implications of malignant melanoma. Br J Plast Surg (1993) 0.76
The financial burden of cancer patients: time to stop averting our eyes. Support Care Cancer (2015) 0.76
Assessing the social impact of cancer: a review of available tools. Support Care Cancer (2012) 0.76
Improvements in measuring the health-related quality of life of cancer patients. Expert Rev Pharmacoecon Outcomes Res (2006) 0.76
Using patient perspectives to inform communication training materials for health care professionals discussing BRCA mutation testing. Breast Cancer Res Treat (2020) 0.75
Talking about risk in the context of genomic tests (TARGET): development and evaluation of an educational program for clinicians. Breast Cancer Res Treat (2019) 0.75